Globus Medical
GMED
450 hedge funds and large institutions have $7.72B invested in Globus Medical in 2024 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 136 increasing their positions, 167 reducing their positions, and 55 closing their positions.
416% more call options, than puts
Call options by funds: $16.1M | Put options by funds: $3.12M
38% more funds holding in top 10
Funds holding in top 10: 16 → 22 (+6)
27% more capital invested
Capital invested by funds: $6.08B → $7.72B (+$1.64B)
25% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 55
3% more funds holding
Funds holding: 439 → 450 (+11)
0.32% less ownership
Funds ownership: 100.41% → 100.09% (-0.32%)
19% less repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 167
Top Buyers
| 1 |
Select Equity Group
New York
|
+$80M |
| 2 |
Millennium Management
New York
|
+$74.5M |
| 3 |
PCM
Parsifal Capital Management
Greenwich,
Connecticut
|
+$53.6M |
| 4 |
MAP
Madison Avenue Partners
New York
|
+$42.6M |
| 5 |
JP Morgan Chase
New York
|
+$31.3M |
Top Sellers
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$57.1M |
| 2 |
BlackRock
New York
|
-$32.5M |
| 3 |
Bank of New York Mellon
New York
|
-$24.1M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$21.5M |
| 5 |
SCM
Sio Capital Management
New York
|
-$21.1M |
GMED Hedge Fund Activity: Q2 2024 in Review
450 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q2 2024, worth a combined $7.72B — up 27% from $6.08B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new GMED positions and 55 closed out — a net gain of 14 holders — while 136 added to existing stakes and 167 trimmed.
The largest buyer was Select Equity Group, opening a new position worth an estimated $80M. The largest seller was Dimensional Fund Advisors, cutting an estimated $57.1M.
- 450 institutional investors held Globus Medical (GMED) as of Q2 2024, up from 439 in Q1 2024.
- Funds reported $7.72B of Globus Medical stock for Q2 2024, up 27% quarter-over-quarter.
- 69 funds opened new Globus Medical positions in Q2 2024 and 55 closed out, a net change of +14 holders.
- The largest Globus Medical buyer in Q2 2024 was Select Equity Group, an estimated $80M added.
- The largest Globus Medical seller in Q2 2024 was Dimensional Fund Advisors, an estimated $57.1M sold.
Based on aggregated 13F filings for Q2 2024.